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Detection of Nausea-Like Response
in Rats by Monitoring Facial
Expression
Kouichi Yamamoto*, Soichi Tatsutani and Takayuki Ishida
Division of Health Sciences, Department of Medical Science and Technology, Graduate School of Medicine, Osaka
University, Osaka, Japan
Patients receiving cancer chemotherapy experience nausea and vomiting. They are not
life-threatening symptoms, but their insufficient control reduces the patients’ quality
of life. To identify methods for the management of nausea and vomiting in preclinical
studies, the objective evaluation of these symptoms in laboratory animals is required.
Unlike vomiting, nausea is defined as a subjective feeling described as recognition of
the need to vomit; thus, determination of the severity of nausea in laboratory animals
is considered to be difficult. However, since we observed that rats grimace after the
administration of cisplatin, we hypothesized that changes in facial expression can be
used as a method to detect nausea. In this study, we monitored the changes in the
facial expression of rats after the administration of cisplatin and investigated the effect
of anti-emetic drugs on the prevention of cisplatin-induced changes in facial expression.
Rats were housed in individual cages with free access to food and tap water, and their
facial expressions were continuously recorded by infrared video camera. On the day of
the experiment, rats received cisplatin (0, 3, and 6 mg/kg, i.p.) with or without a daily
injection of a 5-HT3 receptor antagonist (granisetron: 0.1 mg/kg, i.p.) or a neurokinin
NK1 receptor antagonist (fosaprepitant: 2 mg/kg, i.p.), and their eye-opening index (the
ratio between longitudinal and axial lengths of the eye) in the recorded video image
was calculated. Cisplatin significantly and dose-dependently induced a decrease of
the eye-opening index 6 h after the cisplatin injection, and the decrease continued for
2 days. The acute phase (day 1), but not the delayed phase (day 2), of the decreased
eye-opening index was inhibited by treatment with granisetron; however, fosaprepitant
abolished both phases of changes. The time-course of changes in facial expression
are similar to clinical evidence of cisplatin-induced nausea in humans. These findings
indicate that the monitoring of facial expression has the potential to be useful for the
detection of a nausea-like response in laboratory animals.
Keywords: chemotherapy-induced nausea, facial expression, infrared video camera, rats, neurokinin NK1
receptor antagonist, serotonin 5-HT3 receptor antagonist
INTRODUCTION
Cisplatin-based cancer chemotherapy often induces a biphasic pattern of nausea and vomiting,
which are classified as the acute phase (within 24 h following drug administration) and delayed
phase (24 h after drug administration) (Navari, 2015). To reduce these symptoms, serotonin 5-HT3
receptor antagonists, neurokinin NK1 receptor antagonists, and corticosteroids are used (Jordan
et al., 2015; Natale, 2015; Einhorn et al., 2016; Navari and Aapro, 2016). This regimen proved to
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be significantly effective, but patients still experience nausea,
especially delayed nausea (Molassiotis et al., 2008; Farrell et al.,
2013). Nausea is not life-threatening, but its insufficient control
is a definite factor reducing the patients’ quality of life (Bloechl-
Daum et al., 2006; Farrell et al., 2013; Navari, 2015).
To identify methods to manage chemotherapy-induced
nausea and vomiting in preclinical studies, an objective and
precise method to evaluate nausea and vomiting in laboratory
animals is required. Vomiting is defined as the involuntary
and forceful expulsion of the stomach contents through the
mouth (Quigley et al., 2001); therefore, animal species which
possess a vomiting reflex, such as ferrets, dogs, cats, and
Suncus murinus, are used as laboratory animals for its study,
because the vomiting reflex is a readily detectable behavior
(Florczyk et al., 1982; Ueno et al., 1987; King, 1990). Unlike
vomiting, nausea is defined as an unpleasant feeling in the
upper gastrointestinal tract with an involuntary urge to vomit
(Quigley et al., 2001); thus, it is difficult to recognize whether
laboratory animals feel nausea even with the use of vomiting
species. Rats, one of the most common laboratory animals,
have been considered unsuitable for the study of nausea and
vomiting because they do not show a vomiting reflex (Hatcher,
1924). We previously reported that pica behavior, a behavior
seen in rats characterized by eating non-nutritive materials, such
as clay (kaolin), has been considered as a model of a nausea-
like response or gastrointestinal malaise because it is induced
by nauseant stimuli and the amount of kaolin intake is related
to the nauseant severity in humans (Yamamoto et al., 2007,
2011, 2014, 2015, 2016). However, previous studies reported
that it is difficult to evaluate their nausea-like response by the
amount of kaolin intake, because rats subjected to marked stimuli
showed decreased feeding and locomotive behaviors due to
FIGURE 1 | (A) Experimental apparatus for recoding the rat’s facial expression. It consists of a home cage, turntable, and infra-red camera. In order to record the
facial expression continuously, the home cage was rotated in a clockwise-direction at a rate of 1 degree/sec using a turntable. (B) Representative image of a rat in
the recorded video and method to calculate the eye-opening index. Images of the left lateral side of each rat’s face were captured every 15 min. The longitudinal (Le:
dotted line) and axial (Ae: solid line) lengths of the eye in the captured images were measured, and then the ratio between longitudinal and axial lengths of the eye
was calculated.
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behavioral suppression (Malik et al., 2006, 2007; Cabezos et al.,
2008).
Alternatively, since we observed that rats grimaced after the
administration of cisplatin, we hypothesized that changes in facial
expression could be used as a method to detect a nausea-like
response in rats. In this study, we monitored the changes in the
facial expression of rats after the administration of cisplatin and
investigated the effect of anti-emetic drugs on the prevention of
these cisplatin-induced changes.
MATERIALS AND METHODS
General Procedure
All experiments were approved by the Animal Care Committee
of the School of Allied Health Sciences, Faculty of Medicine,
Osaka University (26-05-01), and were conducted in accordance
with the Animal Experiment Guidelines of Osaka University.
Female Wistar/ST rats (8 weeks old, body weight: 180–210 g)
were obtained from Japan SLC (Shizuoka, Japan) and housed
in individual home cages (25 cm × 20 cm × 20 cm) in a
room with a regular light/dark cycle (lights on 0600–1800 h)
at a constant temperature (approximately 24◦C) and humidity
(approximately 50%). One of the risk factors of chemotherapy-
induced nausea and vomiting is considered to be a female sex
(du Bois et al., 1992). We previously reported that female rats
are more susceptible to the induction of sevoflurane-induced pica
behavior than male rats (Yamamoto et al., 2016); thus, we used
only female rats in a series of experiments. They were allowed
free access to tap water and commercially available standard chow
(CE-2, CLEA Japan, Inc., Tokyo, Japan). During habituation
and the experimental period, the home cage was rotated in a
clockwise-direction at a rate of one degree per second using a
turntable (S-series, Sigma Planning Corporation, Tokyo, Japan)
in order to confirm the facial expression. On the day of the
experiment, rats intraperitoneally (i.p.) received cisplatin (3 or
6 mg/kg) at a volume of 6 mL/kg at 1800 h and the entire
home cage was continuously recorded on motion video (30
frames per second) by an infrared camera (CS-W70HD, Planex
Communications, Inc., Tokyo, Japan), which was placed 30 cm
away from home cage surface, for 2 days after the injection
of cisplatin (see Figure 1A). The doses and injection time of
cisplatin selected in this experiment were determined based on
our previous published data (Yamamoto et al., 2014). Controls
were treated with saline (6 mL/kg body weight, i.p.). At the
end of the experiment, all animals were euthanized by the
intraperitoneal injection of an overdose of sodium pentobarbital
(150 mg/kg). There were six rats in each of the experimental
groups.
Measurement of Eye-Opening Index
Frame images in the recorded motion video were analyzed by
frame-by-frame playback for 5 min every 15 min, and an image
of the left lateral side of each rat’s face in the analyzed part
FIGURE 2 | Effects of cisplatin on the eye-opening index in rats. Cisplatin (3 and 6 mg/kg) was intraperitoneally injected and the three-hourly average
eye-opening index was measured for 2 days after cisplatin administration. There were six rats in each of the experimental groups. Points and bars represent the
mean ± SEM, respectively, of the index. Horizontal black and white bars represent ‘lights off’ and ‘lights on,’ respectively. Differences in the results were analyzed
using the two-way repeated measure analysis of variance (ANOVA), followed by post hoc Bonferroni’s test. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗∗P < 0.0001 vs. saline
control.
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of the video was selected and captured. The longitudinal and
axial lengths of the eye (Figure 1B) in the captured images were
measured by ImageJ analysis software (Version 1.48: developed
by Wayne Rasbands, National Institutes of Health, Bethesda, MD,
USA), and then the ratio between the longitudinal and axial
lengths of the eye (eye-opening index) was calculated, and the
three-hourly average of eye-opening index was measured.
Effects of the 5-HT3 or NK1 Receptor
Antagonist on the Cisplatin-Induced
Nausea-Like Response in Rats
Rats were administered granisetron (5-HT3 receptor antagonist,
0.1 mg/kg, i.p.) or fosaprepitant (NK1 receptor antagonist,
2 mg/kg, i.p.) 30 min before and 24 h after the administration
of cisplatin (3 or 6 mg/kg, i.p.). The doses of granisetron and
fosaprepitant selected in this experiment were determined based
on our previous published data (Yamamoto et al., 2014). Then,
the eye-opening index was obtained using the same method as
in previous experiment, and the three-hourly average of eye-
opening index was analyzed. Control animals received saline
(0.1 ml/100 g body weight, i.p.) as a vehicle.
Cisplatin-Induced Pica Behavior in Rats
To determine the profile of cisplatin-induced pica behavior
and anorexia in female rats, we used an automatic kaolin and
food intake monitoring system (FDM700SW, Melquest, Toyama,
Japan) that we previously developed (Yamamoto et al., 2011).
Briefly, this system is an apparatus to determine the amount of
kaolin and food intakes in rats automatically consisting of an
acrylic home cage (26 cm × 20 cm × 23 cm), two containers
(7 cm × 4 cm × 10 cm), and a controller equipped with two
load cells (weight sensor). Kaolin and food pellets (CE-2, CLEA
Japan, Tokyo, Japan) were provided in their respective containers.
Rats were adapted to the experimental environment for 7 days
and allowed free access to tap water and both pellets throughout
the experimental period. Kaolin and food intakes were monitored
hourly to the nearest 0.01 g and the data were stored and analyzed
using a laptop PC. Kaolin pellets were prepared according to a
previously reported method (Yamamoto et al., 2011). On the day
of the experiment, rats received cisplatin (3 or 6 mg/kg, i.p.) with
or without granisetron or fosaprepitant, and their three hourly
rates of kaolin and food consumption were measured for 2 days
after the injection of cisplatin. Controls were treated with saline
(i.p.). The protocol of drug administration was identical to those
of experiment on measurement of eye-opening index. There were
six rats in each of the experimental groups.
Drugs
Cisplatin [cis-Diamineplatinum(II) dichloride: Sigma-Aldrich,
St. Louis, MO, USA], granisetron hydrochloride (Kytril R©
inj. Chugai-Roche Diagnostics Japan, Tokyo, Japan), and
fosaprepitant dimeglumine (Proemend R©; Ono Pharmaceutical,
FIGURE 3 | Effects of anti-emetic drugs on the eye-opening index in rats treated with cisplatin (3 mg/kg). There were six rats in each of the experimental
groups. Each anti-emetic agent (5-HT3 antagonist: granisetron 0.1 mg/kg, and NK1 antagonist: fosaprepitant 2 mg/kg) or saline was intraperitoneally administered
30 min before and 24 h after the administration of cisplatin. Points and bars represent the mean ± SEM, respectively, of the index. Horizontal black and white bars
represent ‘lights off’ and ‘lights on,’ respectively. Differences in the results were analyzed using the two-way repeated measure ANOVA, followed by post hoc
Bonferroni’s test. ∗P < 0.05 and ∗∗P < 0.01 vs. saline-saline control. †P < 0.05 vs. cisplatin + saline group.
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Osaka) were purchased through a pharmaceutical agency
(Katayama Chemical Industries, Osaka, Japan) and dissolved in
physiological saline. All drugs were prepared immediately before
injection. Gum arabic (Sigma-Aldrich Japan, Tokyo, Japan)
and kaolin (Sigma-Aldrich Japan) were also purchased through
Katayama Chemical Industries. Doses are expressed as the free
base.
Statistical Analysis
The data are expressed as the mean value ± SEM. Differences in
the results of the eye-opening index were analyzed using the two-
way repeated measure analysis of variance (ANOVA), followed by
post hoc Bonferroni’s test. Differences in the results of kaolin and
food intake were analyzed using the one-way ANOVA, followed
by post hoc Dunnett’s multiple comparison test. A P-value of less
than 0.05 was considered significant.
RESULTS
Effects of Cisplatin on Eye-Opening
Index in Rats
Although rats move about in their home cage at all hours of
the day and night, the rotation of the cage using a turntable
allowed us to record each rat’s facial expression. As shown in
Figure 2, there was a prominent circadian variation in the eye-
opening index of control rats. The values in the rats’ dark-active
phase were significantly higher than those in the light-inactive
phase, and a similar tendency was observed on the following
day. Cisplatin at doses of 3 and 6 mg/kg significantly and dose-
dependently decreased the eye-opening index. These decreases
were observed within 6 and 3 h after cisplatin administration,
respectively. Although the decrease continued throughout the
entire observation period, the values in rats treated with cisplatin
at a dose of 6 mg/kg were significantly lower than those in rats
treated with cisplatin at a dose of 3 mg/kg.
Effects of 5-HT3 and NK1 Receptor
Antagonists on Cisplatin-Induced
Decrease of Eye-Opening Index in Rats
Granisetron and fosaprepitant alone did not affect the eye-
opening index throughout the entire period. The decrease of
the eye-opening index induced within 24 h after the injection
of cisplatin at a dose of 3 mg/kg was effectively inhibited by
pretreatment with granisetron, but the decrease on the second
day of cisplatin administration was not completely recovered by
the daily administration of granisetron (Figure 3). On the other
hand, pretreatment with fosaprepitant completely abolished both
phases of cisplatin (3 mg/kg)-induced decrease of the eye-
opening index.
The daily administration of granisetron did not improve the
decrease of the eye-opening index induced by cisplatin at a dose
of 6 mg/kg throughout the entire period (Figure 4). However,
the administration of fosaprepitant significantly inhibited the
cisplatin (6 mg/kg)-induced decrease of the eye-opening index.
FIGURE 4 | Effects of anti-emetic drugs on the eye-opening index in rats treated with cisplatin (6 mg/kg). There were six rats in each of the experimental
groups. Each anti-emetic agent (5-HT3 antagonist: granisetron 0.1 mg/kg, and NK1 antagonist: fosaprepitant 2 mg/kg) or saline was intraperitoneally administered
30 min before and 24 h after the administration of cisplatin. Points and bars represent the mean ± SEM, respectively, of the index. Horizontal black and white bars
represent ‘lights off’ and ‘lights on,’ respectively. Differences in the results were analyzed using the two-way repeated measure ANOVA, followed by post hoc
Bonferroni’s test. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗∗P < 0.0001 vs. saline control. †P < 0.05 vs. cisplatin + saline group.
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FIGURE 5 | Effect of cisplatin on (A) kaolin and (B) food intakes in rats.
Cisplatin (3 and 6 mg/kg) was intraperitoneally injected and three-hourly
cumulative kaolin and food intakes were measured for 2 days after cisplatin
administration. There were six rats in each of the experimental groups. Points
and bars represent the mean ± SEM, respectively, of each intake. Both intake
values are set to zero at 24 h. Horizontal black and white bars represent ‘lights
off’ and ‘lights on,’ respectively. Differences in the results were analyzed using
the one-way ANOVA, followed by post hoc Dunnett’s test. ∗P < 0.05,
∗∗P < 0.01, and ∗∗∗∗P < 0.0001 vs. saline control.
Effects of Cisplatin on Pica Behavior in
Rats
As shown in Figures 5A,B, cisplatin at a dose of 3 mg/kg
induced pica behavior and anorexia, and these behaviors were
continued for 2 days. These behaviors were observed within 3
and 12 h after administration, respectively. On the other hand,
cisplatin at a dose of 6 mg/kg did not induce pica behavior
because all rats ate a small amount of food (less than 7 g) during
the observation period due to severe anorexia. Granisetron and
fosaprepitant alone did not affect kaolin or food intake. The
pica behavior elicited within 24 h after cisplatin (3 mg/kg)
administration was effectively inhibited by pretreatment with
granisetron, but the daily administration of granisetron did not
inhibit pica induced beyond 24 h after cisplatin administration
(Figure 6A) or anorexia throughout the entire observation period
(Figure 6B). However, pretreatment with fosaprepitant abolished
FIGURE 6 | Effects of granisetron or fosaprepitant on cisplatin
(3 mg/kg)-induced (A) pica and (B) anorexia in rats. Granisetron
(0.1 mg/kg), fosaprepitant (2 mg/kg), and saline were intraperitoneally
administered 30 min before and 24 h after cisplatin administration and
three-hourly cumulative kaolin and food intakes were measured for 2 days
after cisplatin administration. There were six rats in each of the experimental
groups. Points and bars represent the mean ± SEM, respectively, of each
intake. Both intake values are set to zero at 24 h. Horizontal black and white
bars represent ‘lights off’ and ‘lights on,’ respectively. Differences in the results
were analyzed using the one-way ANOVA, followed by post hoc Dunnett’s
test. ∗∗P < 0.01 and ∗∗∗∗P < 0.0001 vs. cisplatin + saline group. †P < 0.05
and ‡P < 0.01 vs. cisplatin + saline group.
both phases of pica and anorexia (Figures 6A,B). Neither anti-
emetic drug affected kaolin intake in rats treated with cisplatin
at a dose of 6 mg/kg; however, pretreatment with fosaprepitant,
but not granisetron, significantly improved cisplatin-induced
anorexia (Figures 7A,B), although all rats administered cisplatin
at a dose of 6 mg/kg showed severe anorexia.
DISCUSSION
Quantifying nausea in humans generally involves using a 100-
mm visual analog scale (VAS), which is common in pain
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evaluation (Hendey et al., 2005). However, since this method is
based on subjective evaluation (Wewers and Lowe, 1990), it is
impossible to recognize and evaluate whether animals feel nausea
with this method. Previous studies reported that salivation,
conditioned taste aversion, gaping, secretion of vasopressin,
and gastric stasis are closely associated with the development
of nausea (Andrews and Horn, 2006; Cabezos et al., 2008;
Parker, 2014; Scallan and Simon, 2016), but it is difficult to
accurately measure these parameters in laboratory animals under
physiological conditions. We previously suggested that pica
behavior in rats can be used as a method to assess gastrointestinal
malaise including nausea (Yamamoto et al., 2014, 2015, 2016).
The amount of kaolin intake in rats is proportional to the
emetogenicity in humans (Yamamoto et al., 2007). We also
found that there are sex differences in cisplatin-induced pica
in rats because cisplatin at a dose of 3 mg/kg significantly
induced pica in female but not male rats (Yamamoto et al.,
2014). However, we often could not evaluate their nausea by
the amount of kaolin intake because rats that received severe
emetic stimuli showed decrease of feeding and locomotive
behavior due to behavioral suppression. We actually found
that no rats administered cisplatin at a dose of 6 mg/kg ate
more than 7 g of standard chow and 1 g of kaolin. Moreover,
the anorexia induced by cisplatin at a dose of 6 mg/kg was
resistant to premedication with anti-emetic drugs. Similar results
were also observed by Malik et al. (2006, 2007) and Cabezos
et al. (2008). Pain is also defined as an unpleasant sensory and
emotional experience associated with potential tissue damage
(Ripamonti, 2012). Since we can measure its severity from a
patients’ subjective report, it is also considered that the accurate
evaluation of pain in animals remains impossible. Previous
reports demonstrated that spontaneous pain in animals such
as rats, mice, horses, and rabbits could be evaluated using the
changes of facial expressions, and that patients with severe nausea
change their facial expression to signify distress (Langford et al.,
2010; Sotocinal et al., 2011; Hampshire and Robertson, 2015;
Dalla Costa et al., 2016). We observed that rats made grimaces
after the administration of cisplatin; therefore, we hypothesized
that changes in facial expression can be used as a method to
evaluate the nausea-like response in rats.
Clinically, cisplatin-induced acute nausea occurs within 2 h
and peaks at about 5–6 h after drug administration (Navari
and Aapro, 2016). Delayed nausea begins more than 24 h after
drug administration, and the intensity of this delayed nausea
peaks at around 48 h and persists for about a week (Navari and
Aapro, 2016). In this study, we observed that the administration
of both doses of cisplatin induced a significant decrease of the
eye-opening index in rats. The changes in the facial expression
occurred 3 h after administration, and they were observed on
the following day. The time required to induce these changes
is similar to the latency of cisplatin-induced nausea in humans.
Furthermore, we observed that rats pretreated with anti-emetic
drugs did not show these changes and pica behavior induced
by the lower dose of cisplatin. On the other hand, although
we could not evaluate the effect of the higher dose of cisplatin
based on pica behavior due to suppression of their behavior; we
confirmed that rats treated with cisplatin at a dose of 6 mg/kg
FIGURE 7 | Effects of granisetron or fosaprepitant on cisplatin
(6 mg/kg)-induced (A) pica and (B) anorexia in rats. Granisetron
(0.1 mg/kg), fosaprepitant (2 mg/kg), and saline were intraperitoneally
administered 30 min before and 24 h after cisplatin administration and
three-hourly cumulative kaolin and food intakes were measured for 2 days
after cisplatin administration. There were six rats in each of the experimental
groups. Points and bars represent the mean ± SEM, respectively, of each
intake. Both intake values are set to zero at 24 h. Horizontal black and white
bars represent ‘lights off’ and ‘lights on,’ respectively. Differences in the results
were analyzed using the one-way ANOVA, followed by post hoc Dunnett’s
test. ∗∗P < 0.01 and ∗∗∗∗P < 0.0001 vs. cisplatin + saline group. †P < 0.05
and ‡P < 0.01 vs. cisplatin + saline group.
exhibited a decrease of the eye-opening index, and the decrease
was significantly greater than that in rats administered cisplatin at
a dose of 3 mg/kg. The therapeutic effects of anti-emetic drugs on
the acute and delayed phases of the cisplatin-induced decrease of
the eye-opening index in rats that received an even higher dose of
cisplatin were maintained in our study. Based on these results, it is
possible that the changes in the eye-opening index are also useful
for assessing the nausea-like response in laboratory animals.
In this study, we found that single-treatment with
fosaprepitant significantly inhibited the cisplatin-induced
decrease of the eye-opening index in rats at both doses.
We previously reported that substance P is predominantly
involved in cisplatin-induced pica in rats, and an NK1 receptor
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antagonist is considered to be the most effective treatment for a
chemotherapy-induced nausea-like response in rats (Yamamoto
et al., 2014); however, we recognize that NK1 receptor antagonists
are clinically used in combination with other anti-emetic drugs
such as 5-HT3 receptor antagonists and/or corticosteroids. It will
be necessary to determine the responsible etiology and establish
effective treatment for the nausea-like response in laboratory
animals other than rats by this method.
The administration of cisplatin is known to induce peripheral
neuropathic pain (Jaggi and Singh, 2012). Since Sotocinal et al.
(2011) reported that rats suffering spontaneous pain had a
tendency to close their eyes, it is considered to be difficult
to distinguish accurately between a nausea-like response and
neuropathic pain. Seto et al. (2016) reported that rats treated with
cisplatin at a dose of 4 mg/kg showed mechanical allodynia on
day 6 after the administration. Joseph and Levine (2009) reported
that cisplatin-induced hyperalgesia had a latency to onset of about
2 days, and it was maximal by 3–4 days. From these findings, since
the results of this study are not considered to be due to the early
development of neuropathy, which would probably require more
time to occur, they may indicate a method for the detection of the
nausea-like response in rats. We previously reported that copper
sulfate, lithium chloride, and teriparatide (parathyroid hormone
analog) transiently increased only kaolin consumption without
affecting food consumption in rats (Yamamoto et al., 2004, 2015).
Takeda et al. (1986) reported that rotation stimulation induced
pica behavior in rats. Further experiments will be needed to
determine the change in the eye-opening index induced by these
emetogenic stimuli, that are considered to have a short latency
and short-term effect, in order to distinguish between a nausea-
like response and neuropathic pain.
An advantage of our developed method is that we can collect
data related to a series of continuous behaviors of rats under
physiological conditions because we use an infrared camera
in order to record the facial expression. Furthermore, this
method can be applied to other animal species such as mice,
ferrets, and Suncus murinus as well as rats. A previous study
demonstrated that automatic detection of vomiting in Suncus
murinus (house musk shrew) was possible by the detection
of contour deformation (Huang et al., 2011). Thus, it may
be possible to detect nausea and vomiting simultaneously by
combining these systems.
In summary, the results suggest that the changes in the facial
expression have the potential to be useful for the detection of a
nausea-like response in laboratory animals.
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